He works as a nutritional coach and physician for professional cyclists, and enjoys training and riding along-side them
TB-500") under section S2.3, Growth Factors and Growth Factor Modulators, banned at all times, in and out of competition, for athletes subject to the WADA Code
In COVID-19, increased cases of Takotsubo cardiomyopathy were also observed (54)
In January 2025, Metsera, a New York-based obesity healthcare company, announced positive topline results from its Phase IIa clinical trial for MET-097i, a glucagon-like peptide-1 receptor agonist (GLP-1RA)
447 Nevertheless, CD133-negative cancer cells also demonstrate CSC-like properties, suggesting that CD133 expression alone cannot comprehensively define CSCs